Inozyme Pharma
INZY
#8134
Rank
C$0.27 B
Marketcap
$4.33
Share price
0.67%
Change (1 day)
-26.66%
Change (1 year)

Earnings for Inozyme Pharma (INZY)

Earnings in 2024 (TTM): -C$0.12 Billion

According to Inozyme Pharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$89.94 Million, an increase over its 2022 earnings that were of -C$98.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inozyme Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.12 Billion29.09%
2023 -C$89.94 Million-8.89%
2022 -C$98.71 Million21.24%
2021 -C$81.42 Million-0.69%
2020 -C$81.99 Million174.17%
2019 -C$29.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 57.03%๐Ÿ‡บ๐Ÿ‡ธ USA